搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
搜狐
5 天
PD-1/PD-L1 通路:乳腺癌当前研究情况
摘要:近年来,免疫疗法在乳腺癌(BC)治疗中显示出鼓舞人心的结果。程序性细胞死亡配体1(PD-L1)跨膜蛋白被认为是免疫反应中的共抑制因子,它与程序性细胞死亡蛋白1(PD-1)合作,刺激凋亡,抑制PD-1阳性细胞释放细胞因子,并限制PD-1阳性细胞的生长。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
On running again in 2028
Alabama mass shooting
Daylight saving time
Ga. suspect's mom indicted
San Francisco homelessness
CA firefighter held for arson
CAH sues for trespassing
Actress Crosby dies at 90
To skip Al Smith dinner
Donlon's homes searched
Biden hosts 'Quad' summit
Former WA governor dies
House repeals emission rules
Iran coal mine blast
Suns broadcaster dies
ISR raids Al Jazeera office
Pandas leaving for China
J&J unit files for bankruptcy
No. 1 at box office again
Drug price challenge revived
Beirut strike death toll
Released after guilty plea
Boeing defense chief exits
CA bill to protect kids online
FDA approves flu vaccine
SC 1st execution in 13 years
Sesame Place suit verdict
TN abortion law blocked
ISR strike on Gaza school
反馈